UK Data Shows Zero Cervical Cancer Deaths in Vaccinated Young Women, Japan Models Warn of Thousands of Excess Cases From Trust Collapse
UK registry data demonstrate near-elimination of early cervical cancer mortality in vaccinated cohorts, while Japan’s coverage collapse offers a natural experiment on the population cost of eroded confidence. Sustained uptake above 85% is required to realize elimination targets; any further decline risks measurable reversal within two decades.
The UK national program, launched in 2008 with school-based delivery reaching near 90% uptake, produced an 87% reduction in invasive cervical cancers among women vaccinated at 12-13 years in a direct comparison of vaccinated and unvaccinated cohorts. Absolute incidence fell sharply enough that the NHS published an elimination target for 2040. These results rest on observational linkage of vaccination registers to cancer registries rather than randomization, yet the magnitude and consistency across age groups align with RCT reductions in precancerous lesions. Japan’s 2013 suspension of active recommendation after unconfirmed adverse-event reports cut coverage from 70% to under 1% for multiple birth cohorts. A modeling analysis estimated tens of thousands of additional cases and thousands of deaths over lifetimes, illustrating how loss of endorsement alone can erase population-level gains even when the vaccine remains available.
UK Health Security Agency: Cervical cancer incidence in women aged 25-29 will fall below 4 per 100,000 by 2035 if three-dose uptake remains above 85%.
Sources (3)
- [1]Primary Source(https://medicalxpress.com/news/2026-06-hpv-vaccine.html)
- [2]Supporting Source(https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00978-2)
- [3]Supporting Source(https://www.bmj.com/content/378/bmj-2021-068582)